Results 251 to 260 of about 64,446 (303)

Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Mechanical Heart Valves: A Systematic Review. [PDF]

Cureus
Mandefro BT, Sundara SV, Lu X, Busmail H, Weerakoon S, Avula S, Iftikhar L.   +6 more
europepmc   +1 more source

Bleeding prediction scores in patients with venous thromboembolism using direct oral anticoagulants. [PDF]

Ann Hematol
Wu G, Chen J, Chen Y, Niu P, Chang S, Ma F, Wang C, Lin X, Liu X, Su J, Dai H, Liu Y, Zhang J.   +12 more
europepmc   +1 more source

Real-world adherence trajectories to direct oral anticoagulants in naive patients with atrial fibrillation in Spain. [PDF]

Front Pharmacol
Leguízamo-Martínez LM, Ballarin ME, Hurtado I, Sanfélix-Gimeno G, Sánchez-Sáez F, Sabaté M.   +5 more
europepmc   +1 more source

Effectiveness of direct oral anticoagulants for all-cause mortality and cardiovascular events in overweight and obese patients with atrial fibrillation: Insight from the nationwide START registry. [PDF]

Eur J Clin Invest
Menichelli D, Gazzaniga G, Antonucci E, Palareti G, Poli D, Pignatelli P, Pastori D, START2 Register Investigators.   +7 more
europepmc   +1 more source

Efficacy and safety of direct oral anticoagulants versus warfarin in patients with a left ventricular thrombus: an updated systematic review and meta-analysis of randomised controlled trials. [PDF]

Open Heart
Costa TA, Chagas GCL, Tavares de Sousa LM, Lins de Souza B, Felix N, Harrington J, Lima BB.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Direct Oral Anticoagulants

DeckerMed Critical Care of the Surgical Patient, 2017
Non–vitamin K antagonist oral anticoagulants, also known as direct oral anticoagulants, are a relatively recent class of medications introduced into clinical practice. Due to their safety profiles, fixed dosing, and lack of need for frequent laboratory monitoring, they are becoming preferred to traditional anticoagulation with warfarin in many cases of
Michael G Mount, Panna A. Codner
openaire   +2 more sources

Measuring Direct Oral Anticoagulants

2017
Direct oral anticoagulants (DOACs) can be quantified using methods that can be performed in any clinical or research laboratory using manual or automated instrument platforms. Dabigatran etexilate, the oral direct thrombin inhibitor, can be quantified by drug-calibrated clot or chromogenic-based assays using either thrombin or ecarin as substrates ...
Robert C, Gosselin, Jonathan, Douxfils
openaire   +3 more sources

New anticoagulants: Moving beyond the direct oral anticoagulants

Journal of Thrombosis and Haemostasis, 2021
Although anticoagulants have been in use for more than 80 years, heparin and vitamin K antagonists were the sole available options until recently. Although these agents revolutionized the prevention and treatment of thrombotic diseases, their use has been hampered by the necessity for coagulation monitoring and by bleeding complications resulting in ...
James C. Fredenburgh, Jeffrey I. Weitz
openaire   +2 more sources

Direct Oral Anticoagulants and Women

Seminars in Thrombosis and Hemostasis, 2016
Direct oral anticoagulants (DOACs) provide an effective, safe, and convenient therapeutic alternative to warfarin and other vitamin K antagonists (VKAs), and are now established for a wide range of indications. The use of DOACs in women merits special consideration due to two main situations: first, in relation to fertility, pregnancy, and lactation in
Cohen, Hannah, Arachchillage, Deepa R. J., Beyer-Westendorf, Jan, Middeldorp, Saskia, Kadir, Rezan A.   +4 more
openaire   +2 more sources